Researchers found that women who experience early menopause do not live as long and experience more years with type 2 diabetes mellitus.
The Most Common Bleeding Disorder in Your Patients Could be Hiding in Plain Sight
von Willebrand disease affects up to 1% of the population yet diagnosis is delayed an average of 16 years after onset of symptoms, especially in women.
FDA Approves New Treatment for Uncomplicated UTIs: Daily Dose
Your daily dose of the clinical news you may have missed.
GoodRx, Opill Team Up on OTC Delivery Program for Contraceptive
The new e-commerce partnership expands access to Opill by allowing direct delivery of the contraceptive to consumers' homes without a prescription.
FDA Approves Oral Sulopenem for the Treatment of Uncomplicated Urinary Tract Infections
Oral sulopenem is the first oral penem approved in the US for treating uUTIs in women with limited options.
FDA Updates Flublok Label with Safety Data for Pregnant Individuals
The safety data used to update the Flublok label is from a study of more than 48 000 pregnant women across multiple flu seasons, according to Sanofi.
Elinzanetant Data from Bayer Feature Prominently at 19th World Congress on Menopause
Bayer announced 12 presentations focused on symptoms of menopause and effects of its investigational oral nonhormonal medication elinzanetant.